Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
50Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $179.02M | $-57.29M | $-2.74 |
| 2025 | $226.97M | $-6.27M | $-0.30 |
| 2024 | $274.10M | $-7.46M | $-0.37 |
| 2023 | $256.58M | $5.14M | $0.25 |
| 2022 | $273.42M | $21.10M | $1.05 |
Social Signal Score
Earnings
Tue, Oct 13(in 8 weeks)
Consensus estimate $-0.06 per share
Typical surprise -525.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$-0.28 vs $0.12miss
- Tue, Jun 2$-0.19 vs $-0.18miss
- Thu, Feb 5$-0.50 vs $-0.06miss
- Fri, Dec 19$-0.34 vs $-0.02miss
- Tue, Sep 30$-0.07 vs $-0.06miss
- Tue, Aug 26$-0.49 vs $-0.06miss
Estimates and results for PETS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
PETShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (3)
- Newszacks.com·1d ago·Neutral
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y PETS' fiscal first-quarter 2027 sales decline year over year, but lower costs, stronger recurring sales and new partnerships offer signs of progress.
View source ↗ - Newszacks.com·1d ago·Negative
PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates PetMed (PETS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of $0.12. This compares to a loss of $0.34 per share a year ago.
View source ↗ - Newsseekingalpha.com·1d ago·Neutral
PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript
View source ↗
